PsyBio Therapeutics Announces Retention of Market Maker
March 04, 2021 08:08 ET
|
PsyBio Therapeutics Corp.
TORONTO, March 04, 2021 (GLOBE NEWSWIRE) -- PsyBio Therapeutics Corp. (TSXV:PSYB) (“PsyBio” or the “Company”), a leader in the field of psychedelic research and drug development, announces that,...
PsyBio Therapeutics Initiates Pilot Scale Development of Proprietary Biosynthetic Psilocybin with Global Contract Research, Development and Manufacturing Organization
March 02, 2021 08:30 ET
|
PsyBio Therapeutics Corp.
OXFORD, Ohio and COCONUT CREEK, Fla., March 02, 2021 (GLOBE NEWSWIRE) -- PsyBio Therapeutics Corp. (TSXV:PSYB) (“PsyBio” or the “Company”), a leader in the field of psychedelic research and drug...
PsyBio Announces Second Quarter Financial Results of Leo Acquisition Corp.
March 01, 2021 22:03 ET
|
PsyBio Therapeutics Corp.
TORONTO, March 01, 2021 (GLOBE NEWSWIRE) -- PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) (TSXV:PSYB) (“PsyBio”), a biotechnology company developing a new class of drugs intended for...
PsyBio Therapeutics Corp. Begins Trading on the TSX Venture Exchange
February 25, 2021 08:19 ET
|
PsyBio Therapeutics Corp.
TORONTO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) (TSXV: PSYB) (the “Company”) is pleased to announce that at the opening of the market today,...
PsyBio Completes Reverse Take-Over Transaction
February 19, 2021 15:17 ET
|
PsyBio Therapeutics Corp.
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. TORONTO,...
Leo Acquisitions Announces Filing of Filing Statement in Connection With Qualifying Transaction
February 17, 2021 16:06 ET
|
Leo Acquisitions Corp.
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. TORONTO,...
PsyBio Therapeutics and Leo Acquisitions Announce Closing of CAD$14.5 Million Oversubscribed Private Placement
December 04, 2020 10:49 ET
|
Leo Acquisitions Corp.
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. TORONTO,...
PsyBio Therapeutics and Leo Acquisitions Announce Entering Into of Definitive Agreement for Qualifying Transaction and Upsized Private Placement Financing
December 03, 2020 08:30 ET
|
Leo Acquisitions Corp.
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. ...
Leo Acquisitions and PsyBio Therapeutics Announce the Engagement of Eight Capital as Lead Agent for Private Placement of approximately $5 million
October 26, 2020 10:40 ET
|
Leo Acquisitions Corp.
Not for distribution to United States newswire services or for dissemination in the United States. TORONTO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Leo Acquisitions Corp. (TSXV: LEQ.H) (“Leo” or the...
Leo Acquisitions Enters into Binding Letter of Intent for Qualifying Transaction with PsyBio Therapeutics
October 05, 2020 16:21 ET
|
Leo Acquisitions Corp.
Not for distribution to United States newswire services or for dissemination in the United States. TORONTO, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Leo Acquisitions Corp. (TSXV: LEQ.H) (“Leo” or the...